Evid Science
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Evid Science is developing an AI-driven platform within the pharmaceutical space that ingests the full body of peer‑reviewed literature to extract key data points and assemble evidence. It aims to provide rapid, customized summaries of cost and outcomes data across many therapy combinations, enabling quick comparisons for decision-makers. The company notes years of research and pending patents underpinning its technology. The company is based in El Segundo, California, and operates with a small team. Its stated objective is to serve stakeholders in healthcare and pharmaceutical fields seeking fast access to cost and outcomes information. In 2018, Evid Science announced appointments to its Scientific Advisory Board, including Anil S. Jina and Marc L. Berger, with Ivan Jarry joining the board as managing partner.